ArticleNanomaterials (Basel, Switzerland)2022
Plasma Ag-Modified α-Fe
Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 28 citations in OpenAlex.
- Rational design of a cascade CdS/CScientific reports · 2026Article
- Review of the Versatility and Application Potentials of g-C3N4-Based S-Scheme Heterojunctions in Photocatalytic Antibiotic Degradation.Molecules (Basel, Switzerland) · 2025Review
- Advanced Photocatalytic Nanomaterials for Energy Conversion and Environmental Remediation.Nanomaterials (Basel, Switzerland) · 2023Article
- Recent Advances in Carbon Nitride-Based S-scheme Photocatalysts for Solar Energy Conversion.Materials (Basel, Switzerland) · 2023Review
- Photocatalytic Hydrogen Production and Tetracycline Degradation Using ZnInNanomaterials (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
Low spectral utilization and charge carrier compounding limit the application of photocatalysis in energy conversion and environmental purification, and the rational construction of heterojunction is a promising strategy to break this bottleneck. Herein, we prepared surface-engineered plasma Ag-modified α-Fe
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.